Table 3 Comparison between studied groups regarding final outcome
Beta-blocker group (n = 20) | Control group (n = 20) | Test of sig | p-value | |||
|---|---|---|---|---|---|---|
No | % | No | % | |||
Survival | FE | |||||
Died | 3 | 15.0 | 6 | 30.0 | 1.290 | 0.451 |
Survived | 17 | 85.0 | 14 | 70.0 | ||
ICU stay | FE | |||||
≤ 14 days | 19 | 95.0 | 18 | 90.0 | 0.360 | 1.000 |
> 14 days | 1 | 5.0 | 2 | 10.0 | ||
ICU LOS for patients stayed ≤ 14 days | t | |||||
Mean ± SD | 10.26 ± 2.13 | 11.50 ± 2.71 | 1.549 | 0.130 | ||
Range | 8–14 | 6–14 | ||||
Total hospital stay | FE | |||||
≤ 14 days | 19 | 95.0 | 13 | 65.0 | 5.625 | 0.044* |
> 14 days | 1 | 5.0 | 7 | 35.0 | ||
Total hospital LOS for patients stayed ≤ 14 days | t | |||||
Mean ± SD | 11.16 ± 2.01 | 11.38 ± 2.53 | 0.282 | 0.780 | ||
Range | 8–14 | 6–14 | ||||